Candler Paige has extensive experience in the chronic pain field where she has spent her career researching novel therapeutic targets for precise patient populations. Following her doctoral degree, Candler co-founded Doloromics where they have built a platform to identify novel targets and therapeutics using a human-first approach.
Illumina Accelerator Showcase:
Doloromics has developed a proprietary platform, DOLOReS, to identify novel targets and therapeutics for chronic pain.
Precision Therapeutics for the Treatment of Chronic Pain
We'll cover how Doloromics developed proprietary algorithm to identify novel targets and therapeutics for chronic pain